Fluvoxamine is a More Potent Inhibitor of Lidocaine Metabolism than Ketoconazole and Erythromycinin vitro-Reference-Cited by-同舟云学术

Fluvoxamine is a More Potent Inhibitor of Lidocaine Metabolism than Ketoconazole and Erythromycinin vitro

Published:1999-09 Issue: Volume:85 Page:201-205
ISSN:0901-9928
Container-title:Pharmacology & Toxicology
language:en
Short-container-title:

Author:

Wang Jun-Sheng,Backman Janne T.,Wen Xia,Taavitsainen Päivi,Neuvonen Pertti J.,Kivistö Kari T.

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0773.1999.tb02009.x/fullpdf

Reference20 articles.

1. Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient;Azoulay;Transplant. Proc.,1993

2. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4;Bargetzi;Clin. Pharmacol. Therap.,1989

3. Clinical pharmacokinetics of lignocaine;Benowitz;Clin. Pharmacokin.,1978

4. Dollery, C., (Ed.): Therapeutic drugs (2nd edition), vol 2. Churchill Livingstone, Edinburgh, 1999, pp. L52-L56.

5. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes;Eagling;Brit. J. Clin. Pharmacol.,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism;Current Oncology Reports;2020-02

2. Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac;Drug Metabolism and Disposition;2018-12-14

3. Appendix: Suggested Reading;Dentist's Guide to Medical Conditions, Medications, and Complications;2017-06-02

4. Transplacental Distribution of Lidocaine and Its Metabolite in Peridural Anesthesia Administered to Patients With Gestational Diabetes Mellitus;Reproductive Sciences;2015-01-05

5. Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac;Drug Metabolism and Disposition;2013-08-19